Standout Papers

Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic... 2009 2026 2014 2020 839
  1. Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment (2009)
    Carla M. Prado, Vickie E. Baracos et al. Clinical Cancer Research

Citation Impact

Citing Papers

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
Identification of a Primary Target of Thalidomide Teratogenicity
2010 StandoutScience
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Establishment and characterization of a novel murine model of pancreatic cancer cachexia
2017
Contributing Knowledge to Electronic Knowledge Repositories: An Empirical Investigation1
2005 Standout
The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer☆
2010
Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)
2016
Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer
2014
Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery
2012 Standout
Head and neck squamous cell carcinoma
2020 Standout
Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx™) in human osteosarcoma xenografts
2005
Cancer treatment and survivorship statistics, 2022
2022 Standout
The emerging role of computerized tomography in assessing cancer cachexia
2009
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
2016 Standout
Expanding global access to radiotherapy
2015 Standout
Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma
2012
Effects of an oncologist’s recommendation to exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: a single-blind, randomized controlled trial
2004
Psychosocial interventions for patients with advanced cancer – a systematic review of the literature
2004
Bowel Disorders
2016 Standout
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis
2010
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Interval versus continuous aerobic exercise training in breast cancer survivors—a pilot RCT
2015
Clinical outcomes related to muscle mass in humans with cancer and catabolic illnesses
2013
Hallmarks of aging: An expanding universe
2023 Standout
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Update on anorexia and cachexia
2002
Effects of exercise in patients treated with stem cell transplantation for a hematologic malignancy: A systematic review and meta-analysis
2013
Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
2016
Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer
2011
Definition and classification of cancer cachexia: an international consensus
2011 Standout
Preliminary Assessment of a Neuropathic Pain Treatment and Referral Algorithm for Patients With Cancer
2011
Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes
2015
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
2017 Standout
Therapie chronischer Schmerzen mit oralem retardiertem Oxycodon
2005
Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis
2011
The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma
2017
The pivotal role of cytokines in muscle wasting during cancer
2005
Effect of bisphosphonates on pain and quality of life in patients with bone metastases
2009
Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma
2010
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Understanding the mechanisms and treatment options in cancer cachexia
2012
Cancer-associated cachexia
2018 Standout
Patient decision aids for cancer treatment
2012
Therapeutic effects of aerobic and resistance exercises for cancer survivors: a systematic review of meta-analyses of clinical trials
2018
Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non–Small-Cell Lung Cancer
2016
Understanding and Managing Cancer Cachexia
2003
Impact of exercise on chemotherapy completion rate: A systematic review of the evidence and recommendations for future exercise oncology research
2019
Can a Controlled-Release Oral Dose Form of Oxycodone Be Used as Readily as an Immediate-Release Form for the Purpose of Titrating to Stable Pain Control?
1999
Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?
2013
Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?
2018
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity
2011
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
2006 Standout
Differentiating Sarcopenia and Cachexia Among Patients With Cancer
2016
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Cachexia in cancer patients
2002
Appraisal of current and experimental approaches to the treatment of cachexia
2007
Evaluation of resistance training to improve muscular strength and body composition in cancer patients undergoing neoadjuvant and adjuvant therapy: a meta-analysis
2017
Exercise for People with Cancer: A Clinical Practice Guideline
2017
Role of Activin A and Myostatin in Human Cancer Cachexia
2015
Sarcopenia
2019 Standout
Thalidomide
2004
Microinfusion Using Hollow Microneedles
2005
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Opioid-induced bowel dysfunction in cancer-related pain: Causes, consequences, and a novel approach for its management
2018
Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection
2013
Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable
2019 Standout
Cancer Anorexia-Cachexia Syndrome: Current Issues in Research and Management
2002
Radiation Therapy Infrastructure and Human Resources in Low- and Middle-Income Countries: Present Status and Projections for 2020
2014
Microneedles for drug and vaccine delivery
2012 Standout
The Reliability and Validity of a Modified Total Neuropathy Score-Reduced and Neuropathic Pain Severity Items When Used to Measure Chemotherapy-Induced Peripheral Neuropathy in Patients Receiving Taxanes and Platinums
2010
Cancer-related inflammation and treatment effectiveness
2014 Standout
Exercise rehabilitation in patients with cancer
2012
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Towards a simple objective framework for the investigation and treatment of cancer cachexia: The Glasgow Prognostic Score
2013
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
MetaboAnalyst 3.0—making metabolomics more meaningful
2015 Standout
A Double-Blind, Crossover Study of Controlled-Release Metoclopramide and Placebo for the Chronic Nausea and Dyspepsia of Advanced Cancer
2000
Terminology in cancer cachexia
2012
Financial impact of sarcopenia or low muscle mass – A short review
2018
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
Learning to predict cancer-associated skeletal muscle wasting from 1H-NMR profiles of urinary metabolites
2010
Cancer Therapy–Induced Cardiac Toxicity in Early Breast Cancer
2012
Muscle Wasting Is Associated With Mortality in Patients With Cirrhosis
2011
American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors
2010 Standout
Association of Skeletal Muscle Wasting With Treatment With Sorafenib in Patients With Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled Study
2010
Exercise Therapy and Cardiovascular Toxicity in Cancer
2018
Practical clinical interventions for diet, physical activity, and weight control in cancer survivors
2015
Chemotherapy for advanced gastric cancer
2017 Standout
Meta-analysis of Exercise Training on Vascular Endothelial Function in Cancer Survivors
2018
Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update
2017 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
2016
Ecological momentary assessments among patients with cancer: A scoping review
2019
Cancer treatment and survivorship statistics, 2019
2019 Standout
On Organizational Becoming: Rethinking Organizational Change
2002 Standout
Cardioprotective Effect of β-Adrenoceptor Blockade in Patients With Breast Cancer Undergoing Chemotherapy
2013
Effect of Fish Oil on Appetite and Other Symptoms in Patients With Advanced Cancer and Anorexia/Cachexia: A Double-Blind, Placebo-Controlled Study
2002
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Cardiac MRI in the Assessment of Cardiac Injury and Toxicity From Cancer Chemotherapy
2013
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
2013 Standout
The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop
2015 Standout
Prognostic Factors in Advanced Cancer Patients: Evidence-Based Clinical Recommendations—A Study by the Steering Committee of the European Association for Palliative Care
2005
Muscle Wasting in Cancer Cachexia: Clinical Implications, Diagnosis, and Emerging Treatment Strategies
2010
Efficacy of Exercise Therapy on Cardiorespiratory Fitness in Patients With Cancer: A Systematic Review and Meta-Analysis
2018
Doxorubicin, Cardiac Risk Factors, and Cardiac Toxicity in Elderly Patients With Diffuse B-Cell Non-Hodgkin's Lymphoma
2008
Cracking the code of change.
2001
Modulation of Anthracycline-Induced Cardiotoxicity by Aerobic Exercise in Breast Cancer
2011
Late Cardiac Effects of Cancer Treatment
2012
Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span
2020
Cardiovascular toxicity of biologic agents for cancer therapy.
2014

Works of Edith Pituskin being referenced

Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101 - Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI
2011
Cardiovascular Reserve and Risk Profile of Postmenopausal Women After Chemoendocrine Therapy for Hormone Receptor–Positive Operable Breast Cancer
2007
The rapid access palliative radiotherapy program: blueprint for initiation of a one-stop multidisciplinary bone metastases clinic
2008
Thalidomide in patients with cachexia due to terminal cancer: Preliminary report
1999
Improving access to specialist multidisciplinary palliative care consultation for rural cancer patients by videoconferencing: report of a pilot project
2012
A randomized controlled trial of local injections of hyaluronidase versus placebo in cancer patients receiving subcutaneous hydration
1999
Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.
1998
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
2009 Standout
Cardiovascular Risk Profile of Patients with HER2/neu-Positive Breast Cancer Treated with Anthracycline-Taxane–Containing Adjuvant Chemotherapy and/or Trastuzumab
2007
Cardiopulmonary Function and Age-Related Decline Across the Breast Cancer Survivorship Continuum
2012
Effect of Exercise Training on Peak Oxygen Consumption in Patients with Cancer: A Meta-Analysis
2011
The addition of an audiocassette recording of a consultation to written recommendations for patients with advanced cancer
1999
Rankless by CCL
2026